Antibacterial Soap Decline Likely In Reaction To Triclosan Debate
This article was originally published in The Tan Sheet
Executive Summary
FDA’s recent proposal to amend the OTC antiseptic drug product monograph could impact sales of antibacterial soaps, according to analysts from market research firm Kline & Co. Firms will “likely choose the path of least resistance” and replace controversial ingredient triclosan, they predict.